Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Zanzibar nears HIV treatment goal but young women still at risk
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 75724, member: 636"] Zanzibar got almost every single HIV patient on antiretroviral meds right now, with 96 percent of the 10,241 diagnosed people getting treatment. Women are getting hit way harder than men, though, and the 25 to 34 age group is catching the most STIs that bump up HIV risk. Dr Ali Salim Ali from the Zanzibar AIDS Commission dropped these numbers at a World AIDS Day meeting, pointing out that young women are facing way more danger than young men when it comes to sexually transmitted infections. The stats show about 70 percent of people on treatment are women, and they made up 79 percent of the 23,220 STI cases treated. Outreach programs connected with over 6,400 people from high-risk groups, testing nearly all of them and finding 77 new HIV cases. Officials say Urban District is keeping HIV rates under five percent, but some regions like South and North Unguja are struggling more. The government wants to completely shut down transmission by 2030, but money problems keep making things harder. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Zanzibar nears HIV treatment goal but young women still at risk
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top